Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IDO1 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement IDO1 dans WB, ELISA et IHC. Il présente une réactivité avec des échantillons de Humain.
N° du produit ABIN1169197
405,15 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 2 à 5 jours ouvrables

Aperçu rapide pour IDO1 anticorps (ABIN1169197)

Antigène

Voir toutes IDO1 Anticorps
IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reactivité

  • 111
  • 15
  • 9
  • 1
  • 1
  • 1
Humain

Hôte

  • 105
  • 13
  • 2
  • 1
Souris

Clonalité

  • 90
  • 31
  • 1
Monoclonal

Conjugué

  • 64
  • 7
  • 7
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IDO1 est non-conjugé

Application

  • 82
  • 39
  • 35
  • 29
  • 23
  • 22
  • 17
  • 16
  • 15
  • 9
  • 7
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Clone

ID 177
  • Fonction

    anti-IDO (human), mAb (ID 177)

    Specificité

    Recognizes human IDO1. Detects a band of ~45 kDa by Western blot. Other species not tested.

    Réactivité croisée (Details)

    Other species not tested.

    Attributs du produit

    Monoclonal Antibody. Recognizes human IDO. Detects a band of ~45 kDa by Western blot. Other species not tested. Isotype: Mouse IgG1kappa. Clone: ID 177. Applications: ELISA, IHC, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. IDO catalyzes the first and rate-limiting step in the main pathway of human tryptophan catabolism, the kynurenine pathway. Proinflammatory mediators, such as endotoxin and IFN-gamma induce the expression of IDO in several tissues. IDO-dependent suppression of T-cell responses might function as natural immunoregulatory mechanism. Physiological IDO activity has been implicated in T-cell tolerance to tumors, dysfunctional selftolerance in non-obese diabetic (NOD) mice, and as a protective negative regulator in autoimmune disorders.

    Stérilité

    0.2 μm filtered

    Immunogène

    Recombinant human IDO1.

    Isotype

    IgG1 kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    +4°C

    -20°C

    Stable for at least 1 year after receipt when stored at -20°C.

    Date de péremption

    12 months
  • Antigène

    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

    Autre désignation

    IDO

    Sujet

    Alternate Names/Synonyms: Indoleamine 2,3-dioxygenase 1, IDO, INDO

    Product Description: IDO1 is a heme enzyme that catalyzes the first and rate-limiting step in the main pathway of human tryptophan catabolism, the kynurenine pathway, causing depletion of tryptophan which can lead to halted growth of microbes as well as T cells. IDO1 is an immune checkpoint protein, thought to play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense, neuropathology, immunoregulation and antioxidant activity. Cancer cells are able to evade the immune system is by hijacking the checkpoint proteins. Increased IDO1 protein levels drive growth arrest and apoptosis of the effector T cells, a group of immune cells that mediate the immune system's ability to destroy pathogens. By reducing the number of effector T cells, IDO1 overexpression prevents the immune system from effectively destroying cancer cells. IDO1 overexpression has been observed in a wide range of human cancers such as prostatic, colorectal, pancreatic, cervical, gastric, ovarian, head or lung cancer. Physiological IDO1 activity has been implicated in T cell tolerance to tumors, dysfunctional selftolerance in non-obese diabetic (NOD) mice, and as a protective negative regulator in autoimmune disorders.

    UniProt

    P14902

    Pathways

    Activated T Cell Proliferation
Vous êtes ici:
Chat with us!